- Legal Expert News
- Law Firm News
- Career News
- Headline Legal News
- Legal Trend News
- Legal Business
- Local Court News
- Court Watch
- Legal Interview
- Topics in Legal News
- Press Release
- Politics & Legal
- Market News
- Supreme Court blocks some redrawn North Carolina districts
- Court allows Pennsylvania to redraw GOP-favored district map
- Court rules that Kushner firm must disclose partners' names
- Court rules Puigdemont must return to Spain for re-election
- Analysis: Outside groups may factor in Arkansas court race
- Pennsylvania GOP take gerrymandering case to US high court
- Top Pakistani court orders arrest of escaped police officer
- Malaysia's top court annuls unilateral conversions of minors
- Officials ask court to send Kennedy cousin back to prison
- Court to hear bid to dismiss lawsuit in Freddie Gray case
Chantix is supposed to work by inhibiting nicotine receptors in the brain. Those receptors are controlled by dopamine, a neurotransmitter, the complaint states: "Essentially, Chantix regulates/restricts dopamine and blocks pleasure sensors to depress the normal flux of emotions experiences by humans in daily life."
Brian Kline claims Pfizer concealed and misrepresented the risks of Chantix (varenicline), knew that it was unsafe and had "caused serious injury and death," but failed to warn of it. He claims he took the drug, "which caused the plaintiff to sustain injuries and damages including but not limited to manic behavior, aggressive and violent behavior and diagnosis of psychotic disorder for which the plaintiff was hospitalized in August 2007.
Kline claims Pfizer intentionally excluded from its clinical trials people with histories of depression or psychological disorders. He claims that Chantix is derived from cytosine, and that Pfizer knew or should have known that cytosine was linked as early as 1972 to suicides and attempted suicides.
Kline demands punitive damages. He is represented by Scott Levensten
Legal News Media
Legal News is the top headline legal news provider for lawyers and legalprofessionals. Read law articles and breaking news from law firm's across the United States to get the latest updates. We reserve the right, at our discretion, to change, modify, add, or remove portions of the site at any time. Your This site is solely for your personal use. You are, of course, welcome to print or otherwise copy material from this site for your personal use. However, you may not distribute, exchange, modify, sell or transmit anything you copy from this Site, including but not limited to any text, images, audio and video, for any business, commercial or public purpose. Any unauthorized use of the text, images, audio and video may violate copyright laws, trademark laws, the laws of privacy and publicity and civil and criminal statutes.